{
  "ptid_time": "005_S_2390_2015-07-20",
  "img_path": "/data/qiuhui/data/adni/images/005_S_2390/2015-07-20/t1.nii.gz",
  "img_finding": "",
  "text_data": "Age is 91.8 years. Gender is Female. Education: 12 years. MMSE: 24.0. MoCA: 19.0. Logical Memory: 11.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.37 SUVR (significant elevated); Amyloid beta: 764.50 pg/mL (normal ); Total tau: 484.00 pg/mL (profound elevated); Phosphorylated tau: 45.70 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient shows normal Aβ levels but profound elevations in T-tau and P-tau, along with significant AV45 uptake, suggesting tauopathy rather than amyloid pathology. The MMSE (24) and MoCA (19) scores indicate mild cognitive impairment, but the biomarker profile is more consistent with a neurodegenerative process.  \nDiagnosis: Dementia (likely non-Alzheimer’s tauopathy, e.g., primary age-related tauopathy or PART)  \nConfidence: Medium (clinical scores suggest MCI, but tau biomarkers strongly indicate neurodegeneration)",
  "timestamp": "2025-07-25T21:19:19.048140"
}